Evidence map›Paper›PMID 30197654›Full record

ReviewFrontiers in plant science2018

The Enhancement of Plant Disease Resistance Using CRISPR/Cas9 Technology.

Virginia M G Borrelli, Vittoria Brambilla, Peter Rogowsky, Adriano Marocco, Alessandra Lanubile

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in plant science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 100 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed, 1 pooled it
29.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 1 synthesis or guideline pooled it, 500 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Sustainable Management of Major Fungal Phytopathogens in Sorghum (Journal of fungi (Basel, Switzerland) · 2025
    Review
  17. Article
  18. Review
  19. Review
  20. Review

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Virginia M G BorrelliDepartment of Sustainable Crop Production, Università Cattolica del Sacro Cuore, Piacenza, Italy.
Vittoria BrambillaDepartment of Agricultural and Environmental Sciences - Production, Territory, Agroenergy, University of Milan, Milan, Italy.
Peter RogowskyLaboratoire Reproduction et Développement des Plantes, Université de Lyon, École Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Centre National de la Recherche Scientifique, Institut National de la Recherche Agronomique, Lyon, France.
Adriano MaroccoDepartment of Sustainable Crop Production, Università Cattolica del Sacro Cuore, Piacenza, Italy.
Alessandra LanubileDepartment of Sustainable Crop Production, Università Cattolica del Sacro Cuore, Piacenza, Italy.
Università Cattolica del Sacro Cuore · ITUniversité Claude Bernard Lyon 1 · FRUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genome editing technologies have progressed rapidly and become one of the most important genetic tools in the implementation of pathogen resistance in plants. Recent years have witnessed the emergence of site directed modification methods using meganucleases, zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and clustered regularly interspaced short palindrome repeats (CRISPR)/CRISPR-associated protein 9 (Cas9). Recently, CRISPR/Cas9 has largely overtaken the other genome editing technologies due to the fact that it is easier to design and implement, has a higher success rate, and is more versatile and less expensive. This review focuses on the recent advances in plant protection using CRISPR/Cas9 technology in model plants and crops in response to viral, fungal and bacterial diseases. As regards the achievement of viral disease resistance, the main strategies employed in model species such as

Indexed as

bacteriaCRISPR/Cas9crop improvementdisease resistancefungusgenome editingvirus

Identifiers

PMID30197654
PMCPMC6117396
OpenAlexW2888684269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.